Balfaxar is an anticoagulant reversal agent used to reverse the effects of warfarin (Coumadin) in adults who need an urgent surgery or procedure. It's given as an infusion into the veins (intravenous, IV) as a single dose. Side effects include weakness, anemia, and painful urination.
Normally, your body uses vitamin K to make certain proteins needed to form blood clots. But warfarin (Coumadin) prevents blood clots by stopping vitamin K from working. This means people taking warfarin (Coumadin) usually have fewer of these proteins required to form blood clots, which keeps their blood thin.
Balfaxar is an anticoagulant reversal agent. It contains a mix of these proteins, and it helps to thicken the blood a bit in someone taking warfarin (Coumadin) so they don't bleed out during an urgent surgery or procedure.
Balfaxar starts to work right away, with a full effect within 30 minutes after the end of the infusion.
During the urgent procedure, the most common side effects of Balfaxar reported in studies were pain, wound problems, weakness, anemia, painful urination, and vomiting. Balfaxar also carries a serious warning of serious blood clots. Symptoms of a blood clot might be different depending on the location of the clot. They can include swelling, warmth, or tenderness in the legs. But more seriously, clots can lead to breathing problems, heart attack, or stroke and cause chest pain, difficulty breathing, or weakness of the face, legs, or arms. Call 911 if you have any of these symptoms because this is a medical emergency.
Both Balfaxar and Kcentra are prothrombin complex concentrates used to reverse the effects of warfarin (Coumadin) and have been shown to work as well as each other. The only apparent difference is that Kcentra contains slightly different ingredients compared to Balfaxar.
Yes, Balfaxar contains a small amount of heparin, which is another blood thinner. If you have a history of heparin-induced thrombocytopenia (HIT) and can't receive heparin products, make sure to let your provider know before receiving Balfaxar.